ArticleTranslational lung cancer research2022

Efficacy, prognosis and safety analysis of anti-PD-1/PD-L1 inhibitor rechallenge in advanced lung cancer patients: a cohort study.

Jin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.